ReNeuron
Allotment of shares
Published in Lab Business Week, March 11th, 2007
ReNeuron Group plc announces the proposed issue to StemCells, Inc. (SCI) of 62,543 new ordinary shares of 1p each fully paid up as to nominal value. The issue of shares to SCI shall be made on 19 February 2007 in final satisfaction of the Company's obligations under a subscription and share exchange agreement between, inter alia, the Company and SCI dated 5 July 2005 (as amended). No further shares are due to be issued to SCI pursuant to such agreement.
Keywords: ReNeuron.
This article was prepared by Lab Business Week editors from staff and other reports. Copyright 2007, Lab Business Week via NewsRx.com.
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-03-11)
More Articles from Lab Business Week
- Anemia
Reports from The Jackson Laboratory add new data to research in anemia - Atorvastatin
RANBAXY LAUNCHES ATORVASTATIN IN DENMARK - Bio-Rad Laboratories
BIO-RAD ANNOUNCES THE APPOINTMENT OF NEW BOARD MEMBER - Bioscience
Shedding New Light on Proteorhodopsin - Cancer
Cold Spring Harbor Laboratory Scientists Discover New Gene that Prevents Multiple Types of Cancer - Cancer Vaccines
Carrington Subsidiary DelSite Signs Technology License Agreement With ElSohly Laboratories - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
